Condition (MeSH)
Klippel-Trenaunay-Weber Syndrome
ClinicalTrials.gov lists 8 trials for Klippel-Trenaunay-Weber Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
8 of the 8 trials are tagged with Klippel-Trenaunay-Weber Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Klippel-Trenaunay-Weber Syndrome trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 1 |
| 2021 | 1 |
| 2015 | 1 |
| 2013 | 1 |
| 2010 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Klippel-Trenaunay-Weber Syndrome trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Not applicable | 3 |
| Observational | 3 |
How many Klippel-Trenaunay-Weber Syndrome trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Klippel-Trenaunay-Weber Syndrome trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Kaken Pharmaceutical | 1 |
| Relay Therapeutics, Inc. | 1 |
| Sonablate | 1 |
Which publications cover Klippel-Trenaunay-Weber Syndrome? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 6 publications.
Prevalence (2)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Capillary-lymphatic-venous malformation with segmental distribution | Annual incidence | <1 / 1 000 000 | United States | US | Unspecified |
| Capillary-lymphatic-venous malformation with segmental distribution | Point prevalence | <1 / 1 000 000 | Europe | Not stated | Unspecified |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.